by Eric Christianson | Feb 19, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
Diltiazem and verapamil are two non-dihydropyridine calcium channel blockers (non-DHP CCBs) most commonly used in managing certain cardiac conditions. Even though they fall into the same medication class, these medications have important pharmacological differences...
by Eric Christianson | Feb 16, 2025 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
It can be overwhelming walking into the pharmacy and looking down the vitamin aisle – especially when you finally find a specific supplement, only to discover there are numerous forms lining the shelves. This gets even more challenging when you don’t know which salt...
by Eric Christianson | Jan 12, 2025 | Endocrine Medication and Disease State Clinical Pearls
Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. Understanding possible drug-drug and drug-disease interactions between medications is extremely important for optimizing medication...
by Eric Christianson | Dec 8, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Fosfomycin is an antibiotic (discovered in 1969) that has been making a resurgence in popularity in the last few years due to its activity against both gram-positive and gram-negative bacteria. Currently, it is a treatment option for women with uncomplicated urinary...
by Eric Christianson | Nov 20, 2024 | Renal, Urology, and Electrolytes Case Studies
A 75-year-old female has a history of mild cognitive impairment, GERD, hypertension, osteoarthritis, and overactive bladder. Recognizing the relationship of oxybutynin and cognitive impairment is incredibly important in geriatrics and in the case scenario, we outline...
